Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis

被引:8
|
作者
Tortelli, R. [1 ]
Arcuti, S. [2 ]
Copetti, M. [2 ]
Barone, R. [1 ]
Zecca, C. [1 ]
Capozzo, R. [1 ]
Barulli, M. R. [1 ]
Simone, I. L. [3 ]
Logroscino, G. [1 ,3 ]
机构
[1] Univ Bari A Moro, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Pia Fdn Card G Panico, Lecce, Italy
[2] IRCCS Casa Sollievo Sofferenza, Unit Biostat, Foggia, Italy
[3] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy
来源
ACTA NEUROLOGICA SCANDINAVICA | 2018年 / 138卷 / 01期
关键词
amyotrophic lateral sclerosis; pseudobulbar affect; survival; DISEASE PROGRESSION; ALS; NEUROLOGY; COGNITION; SURVIVAL; LABILITY;
D O I
10.1111/ane.12918
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveTo evaluate whether the presence of pseudobulbar affect (PBA) in an early stage of the disease influences survival in a population-based incident cohort of amyotrophic lateral sclerosis (ALS). MethodsIncident ALS cases, diagnosed according to El Escorial criteria, were enrolled from a prospective population-based registry in Puglia, Southern Italy. The Center for Neurologic Study-Lability Scale (CNS-LS), a self-administered questionnaire, was used to evaluate PBA. Total scores range from 7 to 35. A score 13 was used to identify PBA. Cox proportional hazard models were used for survival analysis. The modified C-statistic for censored survival data was used for models' discrimination. RECursive Partitioning and AMalgamation (RECPAM) analysis was used to identify subgroups of patients with different patterns of risk, depending on baseline characteristics. ResultsWe enrolled 94 sporadic ALS, median age of 64years (range: 26-80). At the censoring date, 65 of 94 (69.2%), 39 of 60 (65.0%), and 26 of 34 (76.5%) patients reached the outcome (tracheotomy/death), in the whole, non-PBA and in the PBA groups, respectively. Kaplan-Meier survival curves for the two subgroups were not significantly different (log-rank test: 1.3, P=.25). The discrimination ability of a multivariable model with demographic and clinical variables of interest was not improved by adding PBA. In the RECPAM analysis, ALSFRSr and the total score of CNS-LS scale (</10) were the most important variables for differentiating all risk categories. ConclusionsThese preliminary results underlie that the presence of PBA at entry negatively influences survival in a specific subgroup of patients with ALS characterized by less functional impairment.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 50 条
  • [41] Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis
    Desport, Jean-Claude
    Marin, Benoit
    Funalot, Benoiet
    Preux, Pierre-Marie
    Couratier, Philippe
    AMYOTROPHIC LATERAL SCLEROSIS, 2008, 9 (05): : 273 - 278
  • [42] Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis
    Jesus, P.
    Fayemendy, P.
    Nicol, M.
    Lautrette, G.
    Sourisseau, H.
    Preux, P. -M.
    Desport, J. -C.
    Marin, B.
    Couratier, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (01) : 97 - 104
  • [43] Prognostic factors in Chinese patients with sporadic amyotrophic lateral sclerosis
    Kawada, Tomoyuki
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 78 : 451 - 451
  • [44] Prognostic value of weight loss in patients with amyotrophic lateral sclerosis
    Steyn, Frederik J.
    Ngo, Shyuan T.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2020, 91 (08): : 813 - 813
  • [45] Plasma creatinine: a potential prognostic biomarker in amyotrophic lateral sclerosis?
    Vucic, Steve
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (02): : 119 - 119
  • [46] Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
    Lu, Ching-Hua
    Macdonald-Wallis, Corrie
    Gray, Elizabeth
    Pearce, Neil
    Petzold, Axel
    Norgren, Niklas
    Giovannoni, Gavin
    Fratta, Pietro
    Sidle, Katie
    Fish, Mark
    Orrell, Richard
    Howard, Robin
    Talbot, Kevin
    Greensmith, Linda
    Kuhle, Jens
    Turner, Martin R.
    Malaspina, Andrea
    NEUROLOGY, 2015, 84 (22) : 2247 - 2257
  • [47] Neurofilament light chain A prognostic biomarker in amyotrophic lateral sclerosis
    Berger, Thomas
    Stueve, Olaf
    NEUROLOGY, 2019, 92 (10) : 451 - 452
  • [48] Comments on marital status is a prognostic factor in amyotrophic lateral sclerosis
    Safiri, S.
    Sullman, M. J. M.
    Ayubi, E.
    ACTA NEUROLOGICA SCANDINAVICA, 2018, 137 (05): : 538 - 538
  • [49] Identification of Regulatory Factors and Prognostic Markers in Amyotrophic Lateral Sclerosis
    Sun, Hualin
    Li, Ming
    Ji, Yanan
    Zhu, Jianwei
    Chen, Zehao
    Zhang, Lilei
    Deng, Chunyan
    Cheng, Qiong
    Wang, Wei
    Shen, Yuntian
    Shen, Dingding
    ANTIOXIDANTS, 2022, 11 (02)
  • [50] A novel quantitative indicator for disease progression rate in amyotrophic lateral sclerosis
    Kobayakawa, Yuko
    Todaka, Koji
    Hashimoto, Yu
    Ko, Senri
    Shiraishi, Wataru
    Kishimoto, Junji
    Kira, Jun-ichi
    Yamasaki, Ryo
    Isobe, Noriko
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 442